Researchers at National Taiwan University Hospital are set to start clinical trials of an anti-viral drug called remdesivir for the treatment of patients with COVID-19. That was the word from the Central Epidemic Command Center on Wednesday. Although the experimental drug was developed to treat people with Ebola, it has shown promise with a COVID-19 patient.
The news comes as different group of researchers announced that they are one step closer to being able to mass-produce remdesivir.
CONNECT
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
YouTube: [ Ссылка ]
Website: [ Ссылка ]
Email: rti@rti.org.tw
#Taiwan #RadioTaiwanInternational #TaiwanNews
